Ironwood Pharmaceuticals (IRWD) EBT Margin Growth (3y) (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,840.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -134.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,626.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,686.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,570.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,487.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -225.00 |
| 10 | Ironwood Pharmaceuticals | 619.48 Mn | 399.01 Mn | - | -210.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210.00 |
| Dec 31, 2025 | -40,425.00 |
| Sep 30, 2025 | -862.00 |
| Jun 30, 2025 | -1,095.00 |
| Mar 31, 2025 | -14,606.00 |
| Dec 31, 2024 | 9,954.00 |
| Sep 30, 2024 | -3,855.00 |
| Jun 30, 2024 | -3,227.00 |
| Mar 31, 2024 | -3,880.00 |
| Dec 31, 2023 | -20,502.00 |
| Sep 30, 2023 | -654.00 |
| Jun 30, 2023 | -103,042.00 |
| Mar 31, 2023 | 5,911.00 |
| Dec 31, 2022 | 2,952.00 |
| Sep 30, 2022 | 4,861.00 |
| Jun 30, 2022 | 4,278.00 |
| Mar 31, 2022 | 9,542.00 |
| Dec 31, 2021 | -1.05 Mn |
| Sep 30, 2021 | 58,045.00 |
| Jun 30, 2021 | 8,660.00 |